Aestus Therapeutics, Inc.

AstraZeneca PLC has entered into an option agreement to acquire two investigational diabetes compounds, PSN821 and PSN842, from the U.K. biopharma company, Prosidion Ltd. , as that company's pare

AstraZeneca PLC has entered into an option agreement to acquire two investigational diabetes compounds, PSN821 and PSN842, from the U.K. biopharma company, Prosidion Ltd. , as that company's pare

In Vitro Diagnostics Mergers & Acquisitions Opko Health Inc. Claros Diagnostics Inc. Opko Health Inc. (drugs and diagnostics) has acquired privately held point-of-care testing company Claros Dia

After numerous spectacular failures, investors and Big Pharma are pulling back from novel pain drug development, but they risk losing out on improving R&D in the field. By Marc Wortman Pain has been a